SCHEMBL22355305

SCHEMBL22355305

CN[C@@H](CCC(=O)OC(C)(C)C)C(=O)OC(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 2/20 0.34
CYP2D6 P10635 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HTT P42858 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KMT2A Q03164 3/20 0.32
POLB P06746 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA7 P43166 1/20 0.31
LMNA P02545 2/20 0.31
P2RY12 Q9H244 2/20 0.31
HDAC3 O15379 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9086263 0.87 L3MBTL1 (0.37) CTSKCYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL17173874 0.81 CYP2D6 (0.36) CTSKCYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL22355214 0.80 LMNA (0.34) CTSKCYP2D6CYP1A2KMT2ACA1
SCHEMBL13876903 0.80 MEN1 (0.40) CTSKCYP2D6KMT2AP2RY12HDAC3
SCHEMBL17178074 0.80 CYP2D6 (0.34) CTSKCYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL18575864 0.80 MEN1 (0.40) CTSKCYP2D6KMT2AP2RY12HDAC3
SCHEMBL23901540 0.79 CTSK (0.33) CTSKCYP2D6CYP1A2CYP2C9CYP2C19
Ammonia Solution, Strong SCHEMBL28163206 0.79 MEN1 (0.39) CTSKCYP2D6KMT2AP2RY12HDAC3
SCHEMBL13711118 0.79 CTSK (0.33) CTSKCYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL22355225 0.78 L3MBTL1 (0.39) CTSKCYP2D6CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020167831-A1 METHOD OF PREPARING A DON PRODRUG FROM L-GLUTAMIC ACID DRACEN PHARMACEUTICALS, INC. (US) 2020-08-20 WO disclosed